The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of p53-ness with chemo-resistance in urothelial cancers treated with neoadjuvant gemcitabine plus cisplatin.
 
Roland Seiler
No Relationships to Disclose
 
Woonyoung Choi
No Relationships to Disclose
 
Lucia L.C. Lam
Employment - GenomeDx
Stock and Other Ownership Interests - GenomeDx
Consulting or Advisory Role - GenomeDx
Patents, Royalties, Other Intellectual Property - GenomeDx
Travel, Accommodations, Expenses - GenomeDx
 
Nicholas Erho
Employment - GenomeDx
Patents, Royalties, Other Intellectual Property - GenomeDx (Inst)
 
Christine Buerki
Employment - GenomeDx
Stock and Other Ownership Interests - GenomeDx
Patents, Royalties, Other Intellectual Property - GenomeDx (Inst)
Travel, Accommodations, Expenses - GenomeDx
 
Elai Davicioni
Employment - GenomeDx
Patents, Royalties, Other Intellectual Property - GenomeDx
 
George N. Thalmann
Consulting or Advisory Role - Med Discovery
 
David James McConkey
Stock and Other Ownership Interests - ApoCell
Honoraria - Millennium
Consulting or Advisory Role - ApoCell
Research Funding - AstraZeneca; Millennium
Patents, Royalties, Other Intellectual Property - McConkey
Travel, Accommodations, Expenses - Millennium
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; BioCancell; Cubist; Janssen; Novartis
Speakers' Bureau - Abbvie; AstraZeneca; Ferring; Novartis
Patents, Royalties, Other Intellectual Property - GenomeDx
Travel, Accommodations, Expenses - Pendopharm